2 HealthTech Stocks up over 20% past 5 days (GBNH, ADGI stock)
Today, the screeners at HealthTechMovers.com picked up 2 HealthTech Stocks up over 20% past 5 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
FinMarketNews.com is looking into these tickers DAWN, MTDR, AVY, CMC, MNST, RTX and more.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Summary: Greenbrook TMS Inc. is a provider of Transcranial Magnetic Stimulation therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, principally in the United States. Greenbrook TMS Inc. is based in TORONTO.
Recent GBNH Stock Price (approx 10:00am EST.): $4.65
Previous Close for GBNH Stock: $3.07
Percentage Price Change Past 5 Days for GBNH stock: +46%
TipRanks.com reports that Greenbrook Tms stock currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating for GBNH stock with an average price target is $6.50.
Click here to get the full story on GBNH stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Adagio Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. Adagio Therapeutics Inc. is based in WALTHAM, Mass.
Recent ADGI Stock Price (approx 10:00am EST.): $4.58
Previous Close for ADGI Stock: $4.2
Percentage Price Change Past 5 Days for ADGI stock: +20%
TipRanks.com reports that Adagio Therapeutics stock currently has n/a analysts offering 12-month price targets and the consensus is a n/a rating for ADGI stock with an average price target is n/a.
Click here to get the full story on ADGI stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The other great tool for charting is TradingView.com, so you might want to check that out too.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
FinMarketNews.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to FinMarketNews.com.